subperiosteal implants
Additively manufactured 3D porous Ti-6Al-4V constructs mimic trabecular bone structure and regulate osteoblast proliferation, differentiation and local factor production in a porosity and surface roughness dependent manner
- 25 October 2014
- Posted by: Subperiosteal Institute
- Category: Study on Osseointegration
Alice Cheng, Aiza Humayun, David J Cohen, Barbara D Boyan, Zvi Schwartz
Full text link : https://pmc.ncbi.nlm.nih.gov/articles/PMC4296567/
Additively Manufactured 3D Porous Ti-6Al-4V Constructs Mimic Trabecular Bone Structure and Regulate Osteoblast Proliferation, Differentiation and Local Factor Production in a Porosity and Surface Roughness Dependent Manner
1. Scientific Reference
- Study Title: Additively Manufactured 3D Porous Ti-6Al-4V Constructs Mimic Trabecular Bone Structure and Regulate Osteoblast Proliferation, Differentiation and Local Factor Production in a Porosity and Surface Roughness Dependent Manner
- Authors: Alice Cheng, Aiza Humayun, David J. Cohen, Barbara D. Boyan, Zvi Schwartz
- Journal: Biofabrication
- Year of Publication: 2014 (final version available in PMC in 2015)
- DOI: 10.1088/1758-5082/6/4/045007
2. Scientific Background
The long-term success of dental and orthopedic implants depends largely on their ability to achieve stable osseointegration. Although titanium and titanium alloys remain the benchmark materials for implant manufacturing, biological and mechanical challenges persist, particularly in patients with compromised bone quality or reduced regenerative capacity.
Recent advances in additive manufacturing have created opportunities to design implant surfaces and structures that more closely resemble native bone architecture. Beyond surface chemistry and roughness, the three-dimensional organization of an implant may influence cellular behavior and tissue integration. Trabecular bone provides a biologically relevant template because of its interconnected porous network and its role in bone remodeling.
Within this context, the present study explored whether laser-sintered Ti-6Al-4V constructs modeled after human trabecular bone could influence osteoblast activity and enhance biological signals associated with bone formation. The work also examined the combined contribution of macro-porosity and micro/nano-scale surface modifications, two parameters of increasing interest in implant dentistry and bone regeneration research.
3. Study Objective
The primary objective was to manufacture porous Ti-6Al-4V constructs using additive manufacturing technology based on the architecture of human trabecular bone and to investigate how different porosity levels affect osteoblast behavior.
The authors specifically sought to determine whether increasing porosity, combined with micro- and nano-scale surface roughness, could modulate osteoblast proliferation, maturation, and the production of local factors involved in osteogenesis and angiogenesis.
4. Methodology
This was an in vitro preclinical study.
A micro-computed tomography scan of a human femoral head was used as the biological template for creating three porous Ti-6Al-4V structures with low, medium, and high porosity. The constructs were manufactured using selective laser sintering and subsequently subjected to blasting, acid etching, and chemical treatments to generate combined micro- and nano-scale surface features.
Material characterization included micro-CT analysis, scanning electron microscopy, surface chemistry assessment, roughness measurements, wettability evaluation, and mechanical testing.
Biological performance was assessed using MG63 human osteoblast-like cells. The investigators evaluated cell viability, DNA content, alkaline phosphatase activity, osteocalcin production, osteoprotegerin secretion, vascular endothelial growth factor (VEGF), and bone morphogenetic proteins BMP-2 and BMP-4.
5. Main Results
The manufactured constructs demonstrated highly interconnected porosity ranging from approximately 15% to 70%. Increasing porosity was associated with larger pore diameters, thinner struts, and a higher surface-area-to-volume ratio. Mechanical testing showed a progressive reduction in compressive modulus as porosity increased.
Cell viability remained high across all groups, indicating good cytocompatibility of the titanium structures. However, DNA content decreased as porosity increased, suggesting reduced cellular proliferation.
In contrast, markers associated with osteoblastic maturation and bone-forming activity increased in the highly porous constructs. Osteocalcin, osteoprotegerin, BMP-2, BMP-4, and VEGF production were all elevated in the higher-porosity groups, particularly in the constructs exhibiting the greatest porosity. These findings indicate a shift from a proliferative phenotype toward a more differentiated osteoblastic profile.
6. Clinical Analysis
The significance of this study lies in its demonstration that implant architecture may influence cellular behavior beyond the effects of surface chemistry alone. The findings suggest that reproducing the complex geometry of trabecular bone can create a biological environment that promotes osteoblast maturation and the secretion of molecules involved in bone formation and vascular development.
From an implant dentistry perspective, these observations support ongoing efforts to develop biomimetic implant surfaces and structures. The increased production of osteogenic mediators such as BMP-2 and BMP-4 may indicate a more favorable environment for bone formation, while elevated VEGF levels suggest enhanced angiogenic signaling, an important component of successful tissue regeneration.
The study also highlights the interplay between structural design and biological response. As porosity increased, so did the available surface area for cell interaction, potentially contributing to the enhanced differentiation profile observed.
Nevertheless, caution is required when interpreting these findings. The study was conducted entirely under laboratory conditions using an osteoblast-like cell line. While the biological trends are compelling, they do not directly establish clinical superiority, improved implant survival, or enhanced osseointegration in patients. Further animal and human investigations would be required before translating these findings into clinical recommendations.
7. Clinical Applications
The results may be relevant to future developments in:
- Dental implant design.
- Patient-specific implant manufacturing.
- Bone regeneration strategies.
- Additive manufacturing of porous implant surfaces.
- Maxillofacial reconstruction.
- Advanced implant-supported rehabilitations.
- CAD/CAM-driven implant production workflows.
- Biomimetic implant engineering.
The study suggests that highly porous titanium structures inspired by trabecular bone architecture could represent a promising direction for enhancing biological interactions at the bone–implant interface. However, these applications remain investigational within the scope of the present work.
8. Level of Evidence, Limitations and Transparency
This publication should be classified as an in vitro preclinical study, which represents a relatively low level of clinical evidence compared with animal studies, prospective clinical trials, or systematic reviews.
Several limitations should be considered. The investigation relied on MG63 osteoblast-like cells and did not include animal or human clinical outcomes. No implant survival data, osseointegration rates, or long-term biological assessments were reported.
The authors disclosed that the study was funded by AB Dental (Jerusalem, Israel). Additional support was provided by the National Science Foundation and the National Institutes of Health. No other conflicts of interest were explicitly identified within the provided material.
9. Key Study Highlights
- Study Type: In vitro preclinical study
- Level of Evidence: Preclinical
- Population or Number of Studies Analyzed: Not applicable
- Number of Patients or Implants: Not specified in the provided material
- Follow-Up Duration: Not applicable
- Primary Outcome: Osteoblast response to porous Ti-6Al-4V constructs
- Main Finding: High-porosity structures promoted greater osteoblast differentiation and increased production of osteogenic and angiogenic factors
- Scientific Conclusion: Trabecular bone-inspired porous titanium constructs combined with micro/nano-scale surface modification positively influence osteoblast maturation
- Key Limitations: Laboratory-based study without clinical validation
10. Scientific Impact
This investigation contributes to the growing body of research exploring how additive manufacturing can be used to create biologically inspired implant structures. Rather than relying on simplified engineered geometries, the authors used human trabecular bone as the structural model, providing a more physiologically relevant approach to implant design.
The study reinforces the concept that implant macroarchitecture may play a critical role in directing cellular behavior. It also supports the idea that combining porous structures with controlled surface topography can influence osteogenic signaling pathways.
From a research perspective, these findings help bridge the gap between material engineering and bone biology. They provide experimental evidence that highly porous titanium constructs may stimulate biological responses associated with bone formation and vascularization, thereby supporting further investigation into next-generation dental and orthopedic implants manufactured through additive technologies.
11. Editorial Conclusion
This preclinical study demonstrates that additive manufacturing can be used to create porous Ti-6Al-4V structures that closely resemble trabecular bone architecture while influencing osteoblast behavior in a porosity-dependent manner. The findings suggest that highly porous biomimetic constructs may enhance cellular differentiation and the production of biological factors associated with bone regeneration. Although promising, these observations remain limited to an in vitro setting and should be interpreted as a foundation for future translational and clinical research rather than as direct evidence of clinical benefit.
